QuidelOrtho Corp

QDEL

QuidelOrtho Corp

QDEL

Insider Sentiment (TTM):

Last Purchase:2026-02-13Last Sale:2025-11-25Shares Purchased (TTM):54,300Shares Sold (TTM):4,026

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:73,881,517Shares Outstanding:68,200,000Institutional Ownership Pct.:108.33%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in In Vitro & In Vivo Diagnostic Substances

IDXX LNTH NEOG NTLA MYGN ACHV

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	140	170	98	152	127	98	144	107	79	119	149	179
Accounts Receivable Net Current	360	417	387	275	286	282	295	270	272	303	331	247
Marketable Securities Current	-	-	-	-	-	0	0	0	0	48	44	45
Assets Current
Assets Current	1,377	1,447	1,367	1,282	1,258	1,219	1,413	1,341	1,212	1,311	1,371	1,308
Inventory Net	612	578	614	579	563	534	577	602	583	578	552	542
Prepaid Expense And Other Assets Current	233	251	236	234	240	262	344	310	279	262	295	296
Assets Held For Sale Not Part Of Disposal Group Cu…	32	32	32	42	42	42	53	53	-	0	-	-
Property Plant And Equipment And Finance Lease Rig…	1,339	1,358	1,323	1,315	1,399	1,380	1,364	1,327	1,441	1,444	1,369	1,376
Operating Lease Right Of Use Asset	158	156	157	157	165	169	175	177	181	170	172	177
Marketable Securities Noncurrent	-	-	-	-	-	0	0	0	0	7	12	25
Goodwill	-	0	0	711	671	650	771	733	735	2,492	2,443	2,471
Intangible Assets Net Excluding Goodwill	2,520	2,564	2,608	2,661	2,698	2,736	2,796	2,836	2,887	2,934	2,977	3,036
Other Assets Noncurrent	234	244	220	254	270	271	257	251	222	180	179	141
Assets	5,629	5,769	5,675	6,379	6,462	6,424	6,801	6,689	6,703	8,563	8,539	8,550
Deferred Income Tax Assets Net	-	-	-	-	-	0	26	25	25	26	16	16
Liabilities And Stockhold…
Accounts Payable Current	244	279	214	219	231	246	247	237	250	295	253	226
Employee Related Liabilities Current	135	120	104	85	135	117	113	86	109	85	107	82
Liabilities Current
Accrued Income Taxes Current	13	12	1	26	6	5	2	4	10	11	2	2
Liabilities Current	962	966	768	1,142	1,047	999	1,027	932	780	834	860	790
Debt Current	228	178	163	534	394	342	374	356	161	140	193	207
Other Liabilities Current	343	377	287	278	281	289	291	249	251	303	305	273
Operating Lease Liability Noncurrent	155	154	156	156	163	167	174	178	182	173	176	181
Long Term Debt And Capital Lease Obligations	2,460	2,472	2,497	2,072	2,106	2,141	2,177	2,207	2,241	2,275	2,275	2,309
Deferred Income Tax Liabilities Net	87	90	80	83	78	77	117	128	126	192	197	200
Other Liabilities Noncurrent	112	166	139	133	70	55	119	71	67	84	65	69
Liabilities	3,777	3,849	3,639	3,586	3,464	3,439	3,614	3,516	3,396	3,557	3,572	3,548
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	2,943	2,932	2,921	2,909	2,898	2,885	2,876	2,864	2,852	2,848	2,839	2,825
Stockholders Equity	1,851	1,921	2,036	2,793	2,997	2,985	3,187	3,174	3,308	5,006	4,967	5,003
Accumulated Other Comprehensive Income Loss Net Of…	-4	-15	-20	16	-24	-36	-4	-25	-26	-30	-53	-16
Retained Earnings Accumulated Deficit	-1,088	-996	-865	-132	123	136	314	334	482	2,188	2,181	2,194
Liabilities And Stockholders Equity	5,629	5,769	5,675	6,379	6,462	6,424	6,801	6,689	6,703	8,563	8,539	8,550
Accumulated Depreciation Depletion And Amortizatio…	1,000	-	879	826	785	-	-	-	-	-	-	-
Finite Lived Intangible Assets Accumulated Amortiz…	942	-	864	817	767	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	126	126	126	126	126	126	126	126	126	126	126	126
Common Stock Shares Issued	68	68	68	68	68	67	67	67	67	67	67	67
Shares Outstanding	68	68	68	68	68	67	67	67	67	67	67	67

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	18.80%	25.82%	-	-	-	-	-	-	-	-	-	-
2025	-15.88%	-20.82%	-24.88%	22.40%	20.86%	30.16%	28.65%	37.82%	32.13%	-27.57%	-41.34%	-54.26%
2024	1.31%	-23.84%	-10.80%	7.17%	8.10%	-2.79%	-6.29%	1.14%	1.12%	-9.68%	-36.73%	-15.89%
2023	-	-	-	9.64%	-4.25%	-20.06%	11.04%	17.90%	13.69%	2.63%	-14.21%	-6.10%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.43	1.50	1.78	1.12	1.20	1.22	1.38	1.44	1.55	1.57	1.59	1.66
Quick Ratio	0.55	0.64	0.67	0.41	0.43	0.42	0.48	0.46	0.45	0.56	0.61	0.60
Working Capital	414.60M	481.20M	598.80M	139.40M	211.00M	220.10M	385.30M	408.90M	432.60M	476.70M	511.30M	518.10M
Leverage & Debt
Debt to Equity	2.04	2.00	1.79	1.28	1.16	1.15	1.13	1.11	1.03	0.71	0.72	0.71
Interest Coverage TTM	-5.21	-5.18	-5.70	-1.42	-1.04	-11.99	-11.41	-11.72	-11.46	0.94	5.50	6.04
Debt Ratio	0.67	0.67	0.64	0.56	0.54	0.54	0.53	0.53	0.51	0.42	0.42	0.41
Efficiency & Turnover
Asset Turnover TTM	0.44	0.45	0.44	0.42	0.42	0.37	0.37	0.37	0.37	0.34	0.48	0.48
Days Sales Outstanding TTM	44.36	46.75	45.81	36.25	36.81	38.41	40.55	33.23	34.84	46.10	33.09	27.43
Receivables Turnover TTM	8.23	7.81	7.97	10.07	9.91	9.50	9.00	10.98	10.48	7.92	11.03	13.31
Per Share Metrics
Diluted EPS TTM	-17.76	-16.69	-17.35	-6.89	-5.31	-30.54	-27.74	-27.71	-26.38	-0.15	7.37	7.86
Free Cash Flow Per Share TTM	-2.34	-1.22	-2.25	0.19	-0.53	-1.67	-1.44	-2.54	-1.78	1.06	2.19	1.62
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	44.96%	46.67%	47.15%	47.29%	46.94%	46.23%	47.57%	47.89%	48.13%	49.85%	55.90%	56.29%
Operating Profit Margin TTM	-37.02%	-33.67%	-35.12%	-8.52%	-6.16%	-70.46%	-64.61%	-63.82%	-60.03%	4.64%	19.55%	20.09%
Net Profit Margin TTM	-45.57%	-41.45%	-43.45%	-17.01%	-12.97%	-73.74%	-66.25%	-65.60%	-61.65%	-0.34%	11.96%	12.61%
Growth Metrics
Net Revenue Growth (1Y)	-3.89%	-1.89%	-3.67%	-3.28%	-3.42%	-7.17%	-31.68%	-31.92%	-30.38%	-	-	-
Net Income Growth (1Y)	237.58%	-44.84%	-36.81%	-74.92%	-79.68%	20,216.83%	-478.54%	-454.17%	-395.38%	-	-	-
EPS Growth (1Y)	234.12%	-45.33%	-37.46%	-75.14%	-79.86%	20,095.90%	-476.29%	-452.59%	-394.06%	-	-	-
Valuation Metrics
P/E TTM	-0.93	-1.71	-1.70	-4.18	-6.58	-1.46	-1.64	-1.20	-1.82	-487.44	9.91	10.54
P/B TTM	0.61	1.01	0.98	0.70	0.79	1.00	0.96	0.70	0.97	0.98	0.98	1.11
P/S TTM	0.42	0.71	0.74	0.71	0.85	1.08	1.09	0.79	1.12	1.64	1.18	1.33
Market Cap	1.12B	1.94B	2.00B	1.95B	2.36B	2.99B	3.07B	2.23B	3.21B	4.92B	4.89B	5.54B
Enterprise Value	3.67B	4.42B	4.56B	4.41B	4.73B	5.38B	5.48B	4.69B	5.53B	7.22B	7.20B	7.87B
Calculated Values
Free Cash Flow TTM	-159.40M	-83.00M	-153.10M	13.00M	-35.90M	-112.10M	-96.80M	-170.10M	-118.80M	70.90M	146.80M	108.50M
Net Debt	2.55B	2.48B	2.56B	2.45B	2.37B	2.38B	2.41B	2.46B	2.32B	2.30B	2.32B	2.34B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-13Purchase

Owner: Blaser, Brian J.

Title: President and CEO

Shares: 10,540

Price/Share: $23.59

Value: $248,638.60

Shares Owned: 40,073

Relationship: Officer

Ownership: Indirect

2026-02-13Purchase

Owner: Strobeck, Matthew

Title: -

Shares: 10,000

Price/Share: $23.96

Value: $239,600.00

Shares Owned: 27,775

Relationship: Director

Ownership: Direct

2026-02-13Purchase

Owner: Busky, Joseph M.

Title: Chief Financial Officer

Shares: 3,370

Price/Share: $23.66

Value: $79,734.20

Shares Owned: 10,290

Relationship: Officer

Ownership: Indirect

2025-12-10Purchase

Owner: Rhoads, Ann D

Title: -

Shares: 750

Price/Share: $28.28

Value: $21,210.00

Shares Owned: 15,021

Relationship: Director

Ownership: Direct

2025-11-26Purchase

Owner: Wilkins, Joseph D Jr.

Title: -

Shares: 370

Price/Share: $27.96

Value: $10,345.20

Shares Owned: 11,876

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-13	Blaser, Brian J.	Officer	President and CEO	Indirect	Purchase	10,540	23.59	$248,638.60	40,073	4
2026-02-13	Strobeck, Matthew	Director	-	Direct	Purchase	10,000	23.96	$239,600.00	27,775	4
2026-02-13	Busky, Joseph M.	Officer	Chief Financial Officer	Indirect	Purchase	3,370	23.66	$79,734.20	10,290	4/A
2025-12-10	Rhoads, Ann D	Director	-	Direct	Purchase	750	28.28	$21,210.00	15,021	4
2025-11-26	Wilkins, Joseph D Jr.	Director	-	Direct	Purchase	370	27.96	$10,345.20	11,876	4
2025-11-25	Widder, Kenneth J	Director	-	Direct	Sale	4,026	27.81	$111,963.06	37,061	4
2025-11-24	Busky, Joseph M.	Officer	Chief Financial Officer	Indirect	Purchase	4,770	26.06	$124,306.20	6,920	4
2025-11-21	Polan, Mary Lake Ph D	Director	-	Direct	Purchase	1,000	22.43	$22,430.00	12,640	4
2025-11-19	Blaser, Brian J.	Officer	President and CEO	Indirect	Purchase	23,500	21.34	$501,490.00	29,533	4
2024-12-11	Blaser, Brian J.	Officer	President and CEO	Indirect	Purchase	6,033	41.42	$249,886.86	6,033	4
2024-11-21	Tc, Group Cayman Investme…	TenPercentOwner	-	Indirect	Sale	8,260,183	35.31	$291,667,061.73	0	4
2024-08-09	Tc, Group Cayman Investme…	TenPercentOwner	-	Indirect	Sale	74,134	41.20	$3,054,320.80	8,260,183	4
2024-08-08	Tc, Group Cayman Investme…	TenPercentOwner	-	Indirect	Sale	106,705	40.12	$4,281,004.60	8,334,317	4
2024-08-06	Carlyle, Group Inc., Carl…	TenPercentOwner	-	Indirect	Sale	86,972	40.06	$3,484,098.32	8,519,202	4
2024-08-02	Tc, Group Cayman Investme…	TenPercentOwner	-	Indirect	Sale	169,467	41.50	$7,032,880.50	8,724,346	4
2024-07-31	Carlyle, Partners Vi Caym…	TenPercentOwner	-	Indirect	Sale	164,877	38.97	$6,425,256.69	9,128,748	4
2024-07-29	Tc, Group Cayman Investme…	TenPercentOwner	-	Indirect	Sale	158,090	38.92	$6,152,862.80	9,444,215	4
2024-07-25	Cg, Subsidiary Holdings L…	TenPercentOwner	-	Indirect	Sale	406,809	38.78	$15,776,053.02	9,706,231	4
2024-07-23	Carlyle, Holdings Ii Gp L…	TenPercentOwner	-	Indirect	Sale	99,545	36.39	$3,622,442.55	10,327,772	4
2024-07-19	Carlyle, Partners Vi Caym…	TenPercentOwner	-	Indirect	Sale	65,636	33.64	$2,207,995.04	10,562,558	4
2024-07-17	Tc, Group Cayman Investme…	TenPercentOwner	-	Indirect	Sale	69,637	34.91	$2,431,027.67	10,730,064	4
2024-07-15	Carlyle, Group Inc., Carl…	TenPercentOwner	-	Indirect	Sale	93,187	31.92	$2,974,529.04	10,894,562	4
2024-07-11	Cg, Subsidiary Holdings L…	TenPercentOwner	-	Indirect	Sale	96,578	31.37	$3,029,651.86	11,045,002	4
2024-07-09	Carlyle, Holdings Ii L.L.…	TenPercentOwner	-	Indirect	Sale	23,781	30.07	$715,094.67	11,165,970	4
2024-07-05	Tc, Group Vi Cayman, L.L.…	TenPercentOwner	-	Indirect	Sale	50,739	31.02	$1,573,923.78	11,249,724	4
2024-07-02	Carlyle, Partners Vi Caym…	TenPercentOwner	-	Indirect	Sale	86,454	31.16	$2,693,906.64	11,353,187	4
2024-06-28	Tc, Group Cayman Investme…	TenPercentOwner	-	Indirect	Sale	49,937	33.00	$1,647,921.00	11,520,751	4
2024-06-26	Cg, Subsidiary Holdings L…	TenPercentOwner	-	Indirect	Sale	81,482	33.08	$2,695,424.56	11,617,068	4
2024-06-24	Carlyle, Holdings Ii Gp L…	TenPercentOwner	-	Indirect	Sale	73,713	34.46	$2,540,149.98	11,766,022	4
2024-06-20	Carlyle, Group Inc., Tc G…	TenPercentOwner	-	Indirect	Sale	67,207	34.96	$2,349,556.72	11,908,315	4
2024-06-17	Cg, Subsidiary Holdings L…	TenPercentOwner	-	Indirect	Sale	99,642	36.00	$3,587,112.00	12,024,063	4
2024-06-13	Carlyle, Holdings Ii L.L.…	TenPercentOwner	-	Indirect	Sale	144,234	37.96	$5,475,122.64	12,251,686	4
2024-02-23	Busky, Joseph M	Officer	Chief Financial Officer	Indirect	Purchase	2,150	46.36	$99,674.00	2,150	4
2023-02-17	Buechler, Kenneth F	Director	-	Direct	Sale	8,081	90.26	$729,391.06	70,288	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

108.33%

Inst. Shares: 73,881,517

Shares Outstanding: 68,200,000

2025-12-31

103.12%

Inst. Shares: 69,912,508

Shares Outstanding: 67,800,000

2025-09-30

103.26%

Inst. Shares: 70,216,822

Shares Outstanding: 68,000,000

2025-06-30

99.22%

Inst. Shares: 67,173,474

Shares Outstanding: 67,700,000

2025-03-31

92.35%

Inst. Shares: 62,336,822

Shares Outstanding: 67,500,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	73,881,517	68,200,000	108.33%
2025-12-31	69,912,508	67,800,000	103.12%
2025-09-30	70,216,822	68,000,000	103.26%
2025-06-30	67,173,474	67,700,000	99.22%
2025-03-31	62,336,822	67,500,000	92.35%
2024-12-31	60,650,257	67,200,000	90.25%
2024-09-30	60,046,307	67,300,000	89.22%
2024-06-30	56,414,462	67,100,000	84.08%
2024-03-31	52,957,528	66,900,000	79.16%
2023-12-31	53,957,197	66,800,000	80.77%
2023-09-30	53,204,495	66,900,000	79.53%
2023-06-30	53,045,784	66,800,000	79.41%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

QuidelOrtho Corp (QDEL) — SEC Financial Statements & Analysis

QuidelOrtho Corp (QDEL) is a in vitro & in vivo diagnostic substances company. QuidelOrtho Corp trades on QDEL: Nasdaq as: QDEL. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), QuidelOrtho Corp reported a -3.89% year-over-year revenue growth, a Gross Profit Margin of 44.96% (TTM), a Debt-to-Equity ratio of 2.04x, a Price-to-Sales (P/S) ratio of 0.42x (TTM), a Price-to-Book (P/B) ratio of 0.61 (TTM), at a market cap of $1.12B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -3.89%
Gross Profit Margin TTM: 44.96%
Debt To Equity: 2.04x
P/S TTM: 0.42x
P/B TTM: 0.61
Market Cap: $1.12B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is QuidelOrtho Corp in?

QuidelOrtho Corp (QDEL) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What is QDEL's market cap?

QuidelOrtho Corp (QDEL) has a market capitalization of $1.12B as of 2026-03-31.

What exchange does QDEL trade on?

QuidelOrtho Corp (QDEL) trades on the QDEL: Nasdaq.

QuidelOrtho Corp (QDEL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.